Browse key industry insights from the report “Cardiac Surgery Instruments Market
Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy,
France, Spain, Italy, Russia, Poland, China, India, Japan, Australia, Brazil, Mexico,
Argentina, South Africa, Saudi Arabia), Application Development Potential, Price
Trends, Competitive Market Share & Forecast, 2017 – 2024” in detail along with the
table of contents:
https://www.gminsights.com/industry-analysis/cardiac-surgery-instruments-market
Coronary artery bypass graft (CABG) should generate significant revenue share over the
forecast period. The growth is attributed due to increased number of coronary heart
disease (CHD). CABG improves blood flow to the heart and decrease the risk of heart
attack. Heart transplantation should contribute for lucrative growth. The growth is
attributed to severe and progressive heart failure that cannot be treated through
medications. In such cases heart transplant is the only effective treatment option which
will drive business growth over the forecast years.
Hospitals should generate significant revenue share over the forecast period. Growing
incidences of cardiac diseases and increasing demand for treatment and diagnosis,
growing geriatric population base and increased number of cardiac surgeries in
hospitals should drive segment growth in future.
U.S. cardiac surgery instruments market should contribute for significant revenue share.
The American Association for Thoracic Surgery is a global organization of more than
1,300 world's foremost cardiothoracic surgeons that represents 41 countries and has
contributed to the care and treatment of cardiothoracic disease across the world. The
American College of Cardiology (ACC) aim to improve cardiovascular health through
education, quality care research and health policy. Such organizations should drive
industry growth over the forecast period. Asia Pacific cardiac surgery instruments
should experience lucrative growth owing to the growing awareness programs,
increased incidence of heart diseases, increasing funds for cardiac research and
development in the healthcare sector.
Some of the companies operating in the market includes Becton, Dickinson and
Company, B. Braun Melsungen, Teleflex, Medline Industries, KLS Martin, Stille, Sklar
Surgical Instruments, Symmetry Surgical, Delacroix-Chevalier, Wexler Surgical, Surgins,
Surtex Instruments, Cardivon Surgical, Rumex International and Scanlan International.
New product launch is the major strategy adopted by the industry players to gain
revenue share.
2 | Page